Breaking News Instant updates and real-time market news.

MYL

Mylan

$36.66

0.19 (0.52%)

10:32
10/02/18
10/02
10:32
10/02/18
10:32

Morning call buyer in Mylan

Morning call buyer in Mylan. Shares up 14c to $36.62 and Jan 40s trade in small lots from $1.17 to 1.20 before 8.6K bought for $1.22. An even 10K opened early-Tuesday and the call option, which has a strike price 9.2% above the stock price, captures one earnings report in early-November. Shares edged up 1.8% to $39.23 on 8/8/18 after the last report, but thanks to a six-day losing skid prior to today's uptick, has shed 6.5% since that time. The Jan 40 call buyer Tuesday seems to be anticipating another leg higher through earnings and into early-2019.

  • 13

    Nov

MYL Mylan
$36.66

0.19 (0.52%)

08/28/18
HCWC
08/28/18
INITIATION
Target $28
HCWC
Buy
Coherus Biosciences initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Jason Kolbert started Coherus Biosciences (CHRS) with a Buy rating and $28 price target. The analyst expects approval of the company's Udencya in both the U.S. and Europe this year. His confidence level is driven by a positive recommendation from the European Committee for Medicinal Products for Human Use in July for marketing authorization of Udencya, a biosimilar compound targeting febrile neutropenia. Coherus announced that the committee reviewed all the new immunogenicity data that were required for the U.S. re-submission too, so the EU recommendation for approval adds a measure of confidence in support of U.S. approval, Kolbert tells investors in a research note. A year-end approval should position Udencya as the second biosimilar in the $4B U.S. marketplace behind Mylan (MYL), which should be launching its product following approval in June, the analyst adds.
08/30/18
GDHS
08/30/18
NO CHANGE
GDHS
Gordon Haskett questions Perrigo tie-up potential following call postponement
In a report published on August 20, Gordon Haskett analyst Don Bilson noted that Mylan (MYL) once claimed that it could generate $800M of synergies from a deal with Perrigo (PRGO) and while that dollar figure may no longer be relevant, the same logic may still be reasonably intact. At that time, he'd also pondered whether Mylan's failed attempt to acquire Perrigo in 2015-16 could be put back together given the troubles facing both companies. Gordon Haskett has flagged to investors that last night Perrigo postponed its investor event to discuss its long-term consumer growth strategies and key operational initiatives, previously planned as a conference call for September 25. Management had emphasized the event over 10 times on its earnings call just 3 weeks ago, the firm also noted.
09/06/18
WELS
09/06/18
NO CHANGE
WELS
Teva, Mylan weakness related to low multiple in Sandoz sale, says Wells Fargo
Wells Fargo analyst David Maris attributes today's weakness in shares of generic drugmakers Teva (TEVA) and Mylan (MYL) to the low sales multiple at which Novartis' (NVS) Sandoz unit is selling a portfolio of generic and branded products to Aurobindo. While Teva and Mylan clearly have very different businesses than the largely commodity and dermatology portfolio Sandoz is selling for $900M, Maris believes some investors are looking at the deal as a proxy for what the commodity portions of their U.S. businesses might be worth, he tells investors. Maris, who has previously voiced caution about generics and generic drug pricing, sees Novartis' deal as another indication that the environment remains challenging.
09/19/18
LEER
09/19/18
NO CHANGE
LEER
Outperform
Leerink 'incrementally positive on state of generics industry following meetings
Leerink analyst Ami Fadia tells investors in a research note that she is "incrementally positive" on the state of the generics industry following investor meetings with the management teams from Outperform-rated Amneal (AMRX), Pfenex and Teligent. Fadia says a key takeaway from the teams is that the FDA is placing additional emphasis on reviewing and approving complex generics, and while there is starting to be more first-to-market approvals, there are also more approvals for the second and third generic entrants. Additionally, Fadia says the complex generic opportunity will likely be characterized by a slower-than-typical launch ramp, but also extended duration of meaningful financial contribution due to less overall competitors vs that for oral-solid generics and that while companies still regard biosimilar assets as attractive, the low penetration for biosimilar Remicade in the U.S., Mylan's (MYL) slow start with Fulphila and extended litigation timelines mean management teams looking to participate in this space are taking a more prudent approach and minimizing their upfront investment.

TODAY'S FREE FLY STORIES

OMI

Owens & Minor

$6.40

-1.54 (-19.40%)

13:24
02/20/19
02/20
13:24
02/20/19
13:24
Periodicals
Owens & Minor working with banks to explore sale, Reuters reports »

Owens & Minor is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

OMI

Owens & Minor

$6.41

-1.53 (-19.27%)

13:20
02/20/19
02/20
13:20
02/20/19
13:20
Hot Stocks
Breaking Hot Stocks news story on Owens & Minor »

Owens & Minor trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

OMI

Owens & Minor

$6.41

-1.53 (-19.27%)

13:18
02/20/19
02/20
13:18
02/20/19
13:18
Hot Stocks
Breaking Hot Stocks news story on Owens & Minor »

Owens & Minor halted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

GOLD

Barrick Gold

$13.98

0.43 (3.17%)

13:17
02/20/19
02/20
13:17
02/20/19
13:17
Hot Stocks
Barrick Gold confirms commitment to Chile as it reviews LATAM strategy »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMI

Owens & Minor

$6.41

-1.53 (-19.27%)

13:17
02/20/19
02/20
13:17
02/20/19
13:17
Periodicals
Breaking Periodicals news story on Owens & Minor »

Owens & Minor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
02/20/19
02/20
13:17
02/20/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$161.80

-0.49 (-0.30%)

, GOOG

Alphabet

$1,114.63

-3.53 (-0.32%)

13:16
02/20/19
02/20
13:16
02/20/19
13:16
On The Fly
#SocialStocks: YouTube updates penalty system, Twitter developing Snapchat-like camera »

Welcome to…

FB

Facebook

$161.80

-0.49 (-0.30%)

GOOG

Alphabet

$1,114.63

-3.53 (-0.32%)

GOOGL

Alphabet Class A

$1,121.14

-5.29 (-0.47%)

TWTR

Twitter

$31.37

-0.27 (-0.85%)

SNAP

Snap

$9.17

-0.11 (-1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

  • 18

    Mar

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
02/20/19
02/20
13:16
02/20/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMI

Owens & Minor

$6.41

-1.53 (-19.27%)

13:15
02/20/19
02/20
13:15
02/20/19
13:15
Hot Stocks
Breaking Hot Stocks news story on Owens & Minor »

Owens & Minor trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

GOOG

Alphabet

$1,114.13

-4.03 (-0.36%)

, GOOGL

Alphabet Class A

$1,121.07

-5.36 (-0.48%)

13:14
02/20/19
02/20
13:14
02/20/19
13:14
Hot Stocks
Google launches hybrid cloud services platform in beta »

According to a blog…

GOOG

Alphabet

$1,114.13

-4.03 (-0.36%)

GOOGL

Alphabet Class A

$1,121.07

-5.36 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

  • 18

    Mar

FLIR

Flir Systems

13:08
02/20/19
02/20
13:08
02/20/19
13:08
Recommendations
Flir Systems analyst commentary  »

Flir Systems price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 12

    Mar

  • 13

    Mar

HBM

Hudbay Minerals

$6.77

0.415 (6.54%)

13:08
02/20/19
02/20
13:08
02/20/19
13:08
Downgrade
Hudbay Minerals rating change  »

Canaccord downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    Feb

CHTR

Charter

$349.25

0.96 (0.28%)

13:02
02/20/19
02/20
13:02
02/20/19
13:02
Hot Stocks
Charter to launch OTT video service Spectrum TV Essentials »

Charter Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 11

    Mar

  • 11

    Mar

KMI

Kinder Morgan

$19.21

0.06 (0.31%)

, ADM

Archer Daniels

$42.00

0.13 (0.31%)

13:01
02/20/19
02/20
13:01
02/20/19
13:01
Periodicals
Kinder Morgan aims to expand Chicago ethanol terminal capacity, Reuters says »

Kinder Morgan (KMI) plans…

KMI

Kinder Morgan

$19.21

0.06 (0.31%)

ADM

Archer Daniels

$42.00

0.13 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    May

HBM

Hudbay Minerals

$6.81

0.46 (7.24%)

13:00
02/20/19
02/20
13:00
02/20/19
13:00
Downgrade
Hudbay Minerals rating change  »

Hudbay Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    Feb

SPY

SPDR S&P 500 ETF Trust

$277.81

-0.08 (-0.03%)

, SPX

S&P 500

$0.00

(0.00%)

12:59
02/20/19
02/20
12:59
02/20/19
12:59
Periodicals
China newspaper warns U.S. tariffs may be 'catastrophic' to markets, FBN says »

According to Megan…

SPY

SPDR S&P 500 ETF Trust

$277.81

-0.08 (-0.03%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRL

Hormel Foods

$42.90

-0.41 (-0.95%)

, NEM

Newmont Mining

$35.44

0.9 (2.61%)

12:57
02/20/19
02/20
12:57
02/20/19
12:57
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

HRL

Hormel Foods

$42.90

-0.41 (-0.95%)

NEM

Newmont Mining

$35.44

0.9 (2.61%)

DPZ

Domino's Pizza

$278.73

-0.71 (-0.25%)

NCLH

Norwegian Cruise Line

$53.53

0.14 (0.26%)

BG

Bunge

$53.11

0.44 (0.84%)

WEN

Wendy's

$17.84

-0.05 (-0.28%)

SFM

Sprouts Farmers Market

$24.39

-0.5 (-2.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 26

    Feb

  • 27

    Feb

  • 03

    Mar

  • 03

    Mar

  • 06

    Mar

  • 14

    Mar

  • 28

    May

ET

Energy Transfer LP

$15.51

-0.13 (-0.83%)

, A

Agilent

$78.07

0.59 (0.76%)

12:57
02/20/19
02/20
12:57
02/20/19
12:57
Earnings
Notable companies reporting after market close »

Notable companies…

ET

Energy Transfer LP

$15.51

-0.13 (-0.83%)

A

Agilent

$78.07

0.59 (0.76%)

ES

Eversource

$70.36

-0.05 (-0.07%)

SNPS

Synopsys

$103.00

1.1 (1.08%)

CPRT

Copart

$52.20

-1.12 (-2.10%)

GDDY

GoDaddy

$71.63

-1.06 (-1.46%)

FTI

TechnipFMC

$24.71

0.76 (3.17%)

ALB

Albemarle

$83.37

0.245 (0.29%)

WPX

WPX Energy

$13.26

0.02 (0.15%)

CAR

Avis Budget

$29.31

-0.27 (-0.91%)

CAKE

Cheesecake Factory

$46.26

-0.23 (-0.49%)

JACK

Jack in the Box

$79.18

-1.77 (-2.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 01

    Mar

  • 03

    Mar

  • 03

    Mar

  • 04

    Mar

  • 05

    Mar

  • 06

    Mar

  • 06

    Mar

  • 08

    Mar

  • 14

    Mar

  • 17

    Mar

  • 20

    Mar

  • 21

    Mar

  • 16

    Jul

  • 17

    Jul

  • 26

    Sep

  • 27

    Sep

UNH

UnitedHealth

$269.44

-0.82 (-0.30%)

, ANTM

Anthem

$312.20

0.5 (0.16%)

12:49
02/20/19
02/20
12:49
02/20/19
12:49
Recommendations
Magellan Health buyout 'reasonable' up to $90 per share, says SVB Leerink »

SVB Leerink analyst Ana…

UNH

UnitedHealth

$269.44

-0.82 (-0.30%)

ANTM

Anthem

$312.20

0.5 (0.16%)

CNC

Centene

$65.13

0.725 (1.13%)

MGLN

Magellan Health

$70.85

5.8 (8.92%)

WCG

WellCare

$278.49

1.42 (0.51%)

HUM

Humana

$308.33

2.98 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 07

    Mar

  • 12

    Mar

  • 19

    Mar

  • 28

    May

XEL

Xcel Energy

$53.90

0.12 (0.22%)

12:45
02/20/19
02/20
12:45
02/20/19
12:45
Hot Stocks
Xcel Energy increases dividend to 40.5c from 38c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

AMAG

Amag Pharmaceuticals

$15.83

-0.19 (-1.19%)

12:45
02/20/19
02/20
12:45
02/20/19
12:45
Conference/Events
Amag Pharmaceuticals has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 27

    Feb

  • 23

    Mar

INST

Instructure

$40.82

-1.75 (-4.11%)

12:44
02/20/19
02/20
12:44
02/20/19
12:44
Recommendations
Instructure analyst commentary  »

Instructure's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

ACET

Aceto

$0.42

-0.625 (-59.81%)

12:41
02/20/19
02/20
12:41
02/20/19
12:41
Hot Stocks
Aceto receives Nasdaq notice due to delay in filing Form 10-Q »

Aceto Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$39.24

0.77 (2.00%)

12:40
02/20/19
02/20
12:40
02/20/19
12:40
Options
Taiwan Semi sees opening put buying »

Taiwan Semi sees opening…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMHC

Houghton Mifflin

$8.94

0.52 (6.18%)

12:37
02/20/19
02/20
12:37
02/20/19
12:37
Hot Stocks
Houghton Mifflin Harcourt launches HMH Audio in-house audio production studio »

Houghton Mifflin Harcourt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.